PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:45 AM ET

Sponsor Check › Sponsor group

PP

Plx Pharma

One sponsor team, 4 deal companies · Houston, TX

Grouped because: 8 shared people, same business address (3 issuers), similar issuer names (2) · 2 issuers also list a director who sits on many unrelated issuers (not used to group) (automatic match from the filings) · not the same sponsor?

4deal companies
$26.2Mreported sold
165investors
41Form D filings
2009–2025active
0new, last 12 mo
Follow this sponsor groupLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Aug 4, 2025 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Plx Pharma is a sponsor group of 4 issuers that PartnerFacts links to one sponsor (shared people, same business address, similar issuer names; automatic match from the filings), filing 41 Form D filings between Jul 2009 and Aug 2025.

What this means One team, 4 deal companies, about 16 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.

Combined reported sold: $26.2M to 165 investors (latest filing per issuer). Industries as reported: Other Health Care (2), Pharmaceuticals (2). Issuers are based in TX (3), NJ (1).

What this means $26.2M raised across the group, about $159K per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.

Principal people: David Jorden (4 issuers, executive officer and director), David Anderson (2 issuers, director), Gary Balkema (2 issuers, director), Gary Mossman (2 issuers, executive officer), John W. Hadden II (2 issuers, director) and 56 more.

What this means The person on the most companies is usually the one running the show; their page lists every deal.

Activity: 0 new offerings in the last 12 months; latest filing Aug 4, 2025.

What this means No new raise filed in the past year.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — 6 court cases matching the name, 7 bankruptcy cases matching the name listed in Key records below.

What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 41 public filings for Plx Pharma and found 14 differences, 3 worth asking the sponsor about: 4 bankruptcy cases name the subject or team members; 7 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Plx Pharma has not run yet — it is joining a line of 40,218 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

6 cases: 2 closed (disposition not in docket feed), 2 judgment, 2 dismissed

Harvest Technologies Corporation v. Cytomedix, Inc. closed
District Court, N.D. New York · No. 1:04-mc-00112 · Filed Nov 4, 2004 · Closed Mar 3, 2005
Role of Cytomedix, Inc.: Defendant · Outcome: Terminated 2005-03-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in NY (not the issuer's state)
Gandy v. Cytomedix Inc judgment
District Court, E.D. Louisiana · No. 2:04-cv-01337 · Filed May 10, 2004 · Closed Jun 8, 2004 · Nature of suit: 190 Other contract actions
Role of Cytomedix Inc: Defendant · Outcome: Terminated 2004-06-08 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for defendant Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in LA (not the issuer's state)
Cytomedix, Inc v. Bennett dismissed
District Court, W.D. Arkansas · No. 6:04-cv-06007 · Filed Nov 14, 2003 · Closed Jul 19, 2004 · Nature of suit: 423 Bankruptcy Withdrawl · Cause: 28:0157 Motion for Withdrawal of Reference
Role of Cytomedix, Inc: Plaintiff · Outcome: Terminated 2004-07-19 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in AR (not the issuer's state)
Cytomedix Inc v. Gandy judgment
District Court, N.D. Illinois · No. 1:03-cv-01824 · Filed Mar 14, 2003 · Closed Jun 8, 2004 · Nature of suit: 423 Bankruptcy withdrawal 28 USC 157
Role of Cytomedix Inc: Plaintiff · Outcome: Terminated 2004-06-08 — FJC Integrated Database disposition: Judgment on consent; judgment for both plaintiff and defendant Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc v. LB Hyperbarics Inc dismissed
District Court, N.D. Illinois · No. 1:02-cv-08281 · Filed Nov 14, 2002 · Closed May 6, 2003 · Nature of suit: Bankruptcy Withdrawl · Cause: 28:0157(c)(1) Findings, Concl. & Proposed Judgment
Role of Cytomedix Inc: Plaintiff · Outcome: Terminated 2003-05-06 — FJC Integrated Database disposition: Dismissed: lack of jurisdiction Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc v. Bennett closed
District Court, N.D. Illinois · No. 1:02-cv-07459 · Filed Oct 17, 2002 · Closed Sep 30, 2003 · Nature of suit: Bankruptcy Withdrawl · Cause: 28:0157 Motion for Withdrawal of Reference
Role of Cytomedix Inc: Plaintiff · Outcome: Terminated 2003-09-30 — FJC Integrated Database disposition: Transfer to another district Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Plx Pharma..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

7 cases: 7 closed (disposition not in docket feed)

PLx Pharma Winddown Corp. closed matched at sponsor-group level (Plx Pharma)
United States Bankruptcy Court, D. Delaware · No. 23-10456 · Filed Apr 13, 2023 · Closed May 14, 2024
Role of PLx Pharma Winddown Corp.: Debtor · Outcome: Case closed 2024-05-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact company name; court in DE (not the issuer's state)
Nuo Therapeutics, Inc. closed
United States Bankruptcy Court, D. Delaware · No. 16-10192 · Filed Jan 26, 2016 · Closed Nov 29, 2017
Role of Nuo Therapeutics, Inc.: Debtor · Outcome: Case closed 2017-11-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact company name; court in DE (not the issuer's state)
Cytomedix Inc v. Harvest Technologies Corporation closed
United States Bankruptcy Court, N.D. Illinois · No. 02-01854 · Filed Dec 4, 2002 · Closed Mar 18, 2003
Role of Cytomedix Inc: Plaintiff · Outcome: Case closed 2003-03-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc v. 21st Century Wound Care Llc closed
United States Bankruptcy Court, N.D. Illinois · No. 02-01803 · Filed Nov 20, 2002 · Closed Sep 26, 2003
Role of Cytomedix Inc: Plaintiff · Outcome: Case closed 2003-09-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc v. Bennett Medical Llc closed
United States Bankruptcy Court, N.D. Illinois · No. 02-01292 · Filed Sep 13, 2002 · Closed Dec 6, 2002
Role of Cytomedix Inc: Plaintiff · Outcome: Case closed 2002-12-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc v. Buza closed
United States Bankruptcy Court, N.D. Illinois · No. 02-01275 · Filed Sep 12, 2002 · Closed Dec 6, 2002
Role of Cytomedix Inc: Plaintiff · Outcome: Case closed 2002-12-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
Cytomedix Inc closed
United States Bankruptcy Court, N.D. Illinois · No. 01-27610 · Filed Aug 7, 2001 · Closed Jan 5, 2004
Role of Cytomedix Inc: Debtor · Outcome: Case closed 2004-01-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
exact former company name; name has one distinctive word; court in IL (not the issuer's state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.

14 differences found between the filings for Plx Pharma — 3 worth asking about (compared 41 filings on Oct 24, 2026)

Worth asking · Sep 21, 1995 – Jun 10, 2024

4 bankruptcy cases name the subject or team members

Bankruptcy case: PLx Pharma Winddown Corp. — filed Apr 13, 2023 · Bankruptcy case: State of Maryland Central Collection Unit v. Benson James — filed May 6, 2024 · Bankruptcy case: Deluccia Scaffold Erectors, Inc. — filed Feb 20, 1996 · Bankruptcy case: Miron Lumber Co., Inc. v. Deluccia — filed Sep 21, 1995

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Delaware ↗Plx Pharma — sponsor group page ↗Docket · United States Bankruptcy Court, D. Maryland ↗BENSON S. JAMES — PartnerFacts page ↗
Sources
Worth asking · Jan 6, 2009 – Mar 11, 2016

7 Form Ds were filed more than 15 days after the first sale

Form D filed 344 days after the first sale — PLX PHARMA INC. · Form D filed 66 days after the first sale — PLX PHARMA INC. · Form D filed 184 days after the first sale — PLX PHARMA INC. · Form D filed 17 days after the first sale — PLX PHARMA INC. · Form D filed 41 days after the first sale — PLX PHARMA INC. · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 19, 2013 ↗PLX PHARMA INC. — PartnerFacts page ↗Form D · Oct 5, 2011 ↗Form D · Jul 9, 2009 ↗
Sources
Note · Jul 22, 2010 – Mar 15, 2023

15 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Mar 15, 2023) · No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Aug 5, 2021) · No amendment in the last 12 months on an offering that may still be open — NANOSPECTRA BIOSCIENCES INC (latest filing Feb 10, 2017) · No amendment in the last 12 months on an offering that may still be open — Nuo Therapeutics, Inc. (latest filing May 20, 2016) · No amendment in the last 12 months on an offering that may still be open — PLX PHARMA INC. (latest filing Mar 11, 2016) · and 10 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Mar 15, 2023 ↗NANOSPECTRA BIOSCIENCES INC — PartnerFacts page ↗Form D/A · Aug 5, 2021 ↗Form D · Feb 10, 2017 ↗
Sources
Note · Nov 16, 2010 – Mar 15, 2023

6 role changes for the same people across filings

Patrick Pace's role changed at NANOSPECTRA BIOSCIENCES INC: executive officer, director → director · David P. Luci's role changed at PLx Pharma Inc.: executive officer, director, promoter → director · David Jorden's role changed at Nuo Therapeutics, Inc.: director → executive officer, director · David Jorden's role changed at PLX PHARMA INC.: director → executive officer · Gary Mossman's role changed at PLX PHARMA INC.: executive officer, director → executive officer · and 1 more

What this means Roles on Form D are self-reported. Ask who runs the company today.

Form D/A · Aug 5, 2021 ↗Form D · Mar 15, 2023 ↗Patrick Pace — PartnerFacts page ↗NANOSPECTRA BIOSCIENCES INC — PartnerFacts page ↗
Sources
Note · Jul 30, 2010 – Nov 7, 2011

Offering amount changed between filings — PLx Pharma Inc.

The Jul 30, 2010 filing says $2,500,000 offered; the Nov 7, 2011 Form D/A says $3,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jul 30, 2010 ↗Form D/A (later) · Nov 7, 2011 ↗PLx Pharma Inc. — PartnerFacts page ↗
Sources
Note · Jul 9, 2009 – May 6, 2022

15 people are written more than one way across the filings

Paul Mintz is written 2 different ways on the filings · Peter Clausen is written 2 different ways on the filings · John W. Hadden II is written 3 different ways on the filings · Scott Pittman is written 2 different ways on the filings · LAWRENCE S ATINSKY is written 2 different ways on the filings · and 10 more

What this means Middle names and suffixes come and go on these forms. Check full legal names against your documents.

Form D · Jun 12, 2018 ↗Form D · May 6, 2022 ↗Paul Mintz — PartnerFacts page ↗Form D · May 20, 2016 ↗
Sources
Note · Apr 22, 2010 – May 6, 2022

Industry group changed between filings — Nuo Therapeutics, Inc.

"Biotechnology" (Apr 22, 2010 to Jun 12, 2018); then "Other Health Care" (May 6, 2022 to Aug 4, 2025).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 22, 2010 ↗Form D · May 6, 2022 ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 9, 2009 – Mar 4, 2019

4 issuers changed their reported size band between filings

Reported revenue range changed between filings — PLx Pharma Inc. · Reported revenue range changed between filings — Nuo Therapeutics, Inc. · Reported revenue range changed between filings — NANOSPECTRA BIOSCIENCES INC · Reported revenue range changed between filings — PLX PHARMA INC.

What this means The size band is self-reported. Ask for current numbers.

Form D · Jul 30, 2010 ↗Form D · Mar 4, 2019 ↗PLx Pharma Inc. — PartnerFacts page ↗Form D · Apr 22, 2010 ↗
Sources
Note · Apr 22, 2010 – May 6, 2022

5 address changes between filings

Address moved from Gaithersburg, MD to Houston, TX — Nuo Therapeutics, Inc. · Address moved from Houston, TX to Sparta, NJ — PLx Pharma Inc. · Address moved from Staten Island, NY to Houston, TX — PLx Pharma Inc. · Address moved from White Plains, NY to Staten Island, NY — PLx Pharma Inc. · Address moved from Rockville, MD to Gaithersburg,, MD — Nuo Therapeutics, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Jun 12, 2018 ↗Form D · May 6, 2022 ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗Form D · Mar 4, 2019 ↗
Sources
Worth asking · Jul 9, 2009 – Jul 30, 2010

2 separate companies in this group use the same name: "PLX PHARMA INC."

CIK 1291520 (first filed Jul 9, 2009, Houston, TX); CIK 1497504 (first filed Jul 30, 2010, Sparta, NJ).

What this means Two legal entities with one name can make it unclear which one you invested in. Match the CIK and the SEC file number on your documents, not just the name.

PLX PHARMA INC. — PartnerFacts page ↗PLx Pharma Inc. — PartnerFacts page ↗EDGAR filer page · CIK 1291520 ↗EDGAR filer page · CIK 1497504 ↗
Sources
Note · Apr 22, 2010 – Aug 4, 2025

Issuer used a different name before — Nuo Therapeutics, Inc.

SEC records list prior names for this filer: Cytomedix, Inc.; Autologous Wound Therapy Inc.; Nuo Therapeutics, Inc; CYTOMEDIX INC; AUTOLOGOUS WOUND THERAPY INC. The current name on file is "Nuo Therapeutics, Inc.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗Nuo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 30, 2010 – Nov 30, 2020

Issuer used a different name before — PLx Pharma Inc.

SEC records list prior names for this filer: Dipexium Pharmaceuticals, Inc.; Dipexium Pharmaceuticals, LLC. The current name on file is "PLx Pharma Inc.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗PLx Pharma Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

6 of 39 offerings report sales commissions totalling $3,913,837; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 4, 2025 D
Nuo Therapeutics, Inc.
File 021-553598
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2024 D
Nuo Therapeutics, Inc.
File 021-524645
$0$0$0None listed on this filingEDGAR ↗
May 22, 2024 D
Nuo Therapeutics, Inc.
File 021-513970
$0$0$0None listed on this filingEDGAR ↗
Dec 22, 2023 D
Nuo Therapeutics, Inc.
File 021-500556
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2023 D
Nuo Therapeutics, Inc.
File 021-489113
$0$0$0None listed on this filingEDGAR ↗
Mar 15, 2023 D
NANOSPECTRA BIOSCIENCES INC
File 021-475955
$0$0$0None listed on this filingEDGAR ↗
May 19, 2022 D
Nuo Therapeutics, Inc.
File 021-446304
$0$0$0None listed on this filingEDGAR ↗
May 6, 2022 D
Nuo Therapeutics, Inc.
File 021-444862
$0$0$0None listed on this filingEDGAR ↗
Aug 5, 2021 D/A
NANOSPECTRA BIOSCIENCES INC
File 021-375044
$0$0$0None listed on this filingEDGAR ↗
Nov 30, 2020 D
PLx Pharma Inc.
File 021-381708
$1,020,325$0$0Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗EDGAR ↗
May 29, 2020 D
PLx Pharma Inc.
File 021-367889
$120,000$0$0Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗EDGAR ↗
Mar 4, 2019 D
PLx Pharma Inc.
File 021-333941
$1,050,000$0$0JMP Securities LLC BrokerCheck CRD 22208 ↗EDGAR ↗
Jun 12, 2018 D
Nuo Therapeutics, Inc.
File 021-314431
$0$0$0None listed on this filingEDGAR ↗
Jun 28, 2017 D
PLx Pharma Inc.
File 021-289624
$1,191,512$0$0
No proceeds are proposed to be used for payments to such persons other than ordinary salary expenses that may be paid out of working capital.
Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗
Janney Montgomery Scott LLC BrokerCheck CRD 463 ↗		EDGAR ↗
Feb 10, 2017 D
NANOSPECTRA BIOSCIENCES INC
File 021-280450
$0$0$0None listed on this filingEDGAR ↗
May 20, 2016 D
Nuo Therapeutics, Inc.
File 021-263573
$0$0$0None listed on this filingEDGAR ↗
Mar 11, 2016 D
PLX PHARMA INC.
File 021-259059
$0$0$0None listed on this filingEDGAR ↗
Dec 15, 2015 D
NANOSPECTRA BIOSCIENCES INC
File 021-253113
$0$0$0None listed on this filingEDGAR ↗
Aug 29, 2014 D
NANOSPECTRA BIOSCIENCES INC
File 021-223887
$0$0$0None listed on this filingEDGAR ↗
Dec 10, 2013 D
Nuo Therapeutics, Inc.
File 021-207744
$240,000 (est.)$0$0BTIG, LLC BrokerCheck CRD 122225 ↗EDGAR ↗
Jul 22, 2013 D
PLx Pharma Inc.
File 021-200029
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 8, 2013 D
PLX PHARMA INC.
File 021-199168
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jun 17, 2013 D
NANOSPECTRA BIOSCIENCES INC
File 021-198131
$0$0$0None listed on this filingEDGAR ↗
Jun 4, 2013 D
NANOSPECTRA BIOSCIENCES INC
File 021-197405
$0$0$0None listed on this filingEDGAR ↗
Jun 4, 2013 D
NANOSPECTRA BIOSCIENCES INC
File 021-197406
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2013 D
PLX PHARMA INC.
File 021-193567
$0$0$0 (est.)None listed on this filingEDGAR ↗
Feb 25, 2013 D
PLx Pharma Inc.
File 021-192357
$0 (est.)$0$0 (est.)None listed on this filingEDGAR ↗
Apr 23, 2012 D
PLx Pharma Inc.
File 021-177069
$0 (est.)$0$0 (est.)None listed on this filingEDGAR ↗
Feb 15, 2012 D
Nuo Therapeutics, Inc.
File 021-173531
$0$0$0None listed on this filingEDGAR ↗
Nov 7, 2011 D/A
PLx Pharma Inc.
File 021-145743
$0 (est.)$0$0 (est.)None listed on this filingEDGAR ↗
Oct 5, 2011 D
PLX PHARMA INC.
File 021-166758
$0$0$0None listed on this filingEDGAR ↗
Jul 26, 2011 D
Nuo Therapeutics, Inc.
File 021-163473
$0$0$0None listed on this filingEDGAR ↗
Jul 26, 2011 D
Nuo Therapeutics, Inc.
File 021-163474
$0$0$0None listed on this filingEDGAR ↗
May 4, 2011 D
Nuo Therapeutics, Inc.
File 021-159274
$0$0$0None listed on this filingEDGAR ↗
Nov 16, 2010 D
NANOSPECTRA BIOSCIENCES INC
File 021-150600
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Nuo Therapeutics, Inc.
File 021-149299
$0$0$0None listed on this filingEDGAR ↗
Aug 9, 2010 D
PLX PHARMA INC.
File 021-146099
$0$0$0None listed on this filingEDGAR ↗
Apr 22, 2010 D
Nuo Therapeutics, Inc.
File 021-140962
$292,000$0$0MAXIM GROUP LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jul 9, 2009 D
PLX PHARMA INC.
File 021-65821
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across all 4 issuers in this group — every filing in our index, latest filing per offering (SEC file number).

Property records 0 documents · 0 ownership records · last checked Oct 24, 2026, 9:34 AM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Plx Pharma in the sources searched.

Not found in sources searched as of Oct 24, 2026, 9:34 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 2014–2026) — 1,031,843 records, loaded Oct 24, 2026, 9:05 AM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 2014–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:05 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Issuers in this group

Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.

SourceIssuerLinked byLocationIndustryFilingsSold (max)InvestorsMin. investment (latest filing)Active
EDGAR ↗PP PLX PHARMA INC.shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group)HOUSTON, TXPharmaceuticals6$9,000,000
offering $2,000,000 · similar: $1,694,259–$16,000,000
51
similar: 1–13
No minimum reported
similar: $10,000–$55,000
2009–2016
EDGAR ↗NT Nuo Therapeutics, Inc.shared people, same business addressHouston, TXOther Health Care16$21,000,000
offering $791,418 · similar: $829,831–$9,999,998
26
similar: 2–15
No minimum reported
similar: $10,000–$54,310
2010–2025
EDGAR ↗PP PLx Pharma Inc.shared people, similar issuer names, director listed on many unrelated issuers (not used to group)SPARTA, NJPharmaceuticals9$18,191,869
offering $18,008,599 · similar: $1,694,259–$16,000,000
37
similar: 1–13
No minimum reported
similar: $10,000–$55,000
2010–2020
EDGAR ↗NB NANOSPECTRA BIOSCIENCES INCshared people, same business addressHOUSTON, TXOther Health Care10$8,614,644
offering $10,066,119 · similar: $829,831–$9,999,998
51
similar: 2–15
No minimum reported
similar: $10,000–$54,310
2010–2023

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Timeline of offerings

SourceFiledIssuerFormIndustryOfferedSold
EDGAR ↗Aug 4, 2025Nuo Therapeutics, Inc.DOther Health Care$791,418$791,418
EDGAR ↗Sep 23, 2024Nuo Therapeutics, Inc.DOther Health Care$849,125$849,125
EDGAR ↗May 22, 2024Nuo Therapeutics, Inc.DOther Health Care$650,875$650,875
EDGAR ↗Dec 22, 2023Nuo Therapeutics, Inc.DOther Health Care$962,500$962,500
EDGAR ↗Aug 8, 2023Nuo Therapeutics, Inc.DOther Health Care$1,035,000$1,035,000
EDGAR ↗Mar 15, 2023NANOSPECTRA BIOSCIENCES INCDOther Health Care$10,066,119$6,066,104
EDGAR ↗May 19, 2022Nuo Therapeutics, Inc.DOther Health Care$407,757$407,757
EDGAR ↗May 6, 2022Nuo Therapeutics, Inc.DOther Health Care$3,550,000$3,550,000
EDGAR ↗Aug 5, 2021NANOSPECTRA BIOSCIENCES INCD/AOther Health Care$11,264,664$8,614,644
EDGAR ↗Nov 30, 2020PLx Pharma Inc.DPharmaceuticals$18,008,599$18,008,599
EDGAR ↗Sep 8, 2020NANOSPECTRA BIOSCIENCES INCDOther Health Care$11,264,664$6,857,358
EDGAR ↗May 29, 2020PLx Pharma Inc.DPharmaceuticals$8,000,000$8,000,000
EDGAR ↗Mar 4, 2019PLx Pharma Inc.DPharmaceuticals$15,000,000$15,000,000
EDGAR ↗Jun 12, 2018Nuo Therapeutics, Inc.DBiotechnology$500,000$500,000
EDGAR ↗Jun 28, 2017PLx Pharma Inc.DPharmaceuticals$18,191,869$18,191,869
EDGAR ↗Feb 10, 2017NANOSPECTRA BIOSCIENCES INCDOther Health Care$4,166,391$2,026,497
EDGAR ↗May 20, 2016Nuo Therapeutics, Inc.DBiotechnology$10,500,000$7,500,000
EDGAR ↗Mar 11, 2016PLX PHARMA INC.DPharmaceuticals$2,000,000$1,297,000
EDGAR ↗Dec 15, 2015NANOSPECTRA BIOSCIENCES INCDOther Health Care$1,200,000$945,995
EDGAR ↗Aug 29, 2014NANOSPECTRA BIOSCIENCES INCDOther Health Care$800,000$800,000
EDGAR ↗Dec 10, 2013Nuo Therapeutics, Inc.DBiotechnology$3,000,000$3,000,000
EDGAR ↗Jul 22, 2013PLx Pharma Inc.DPharmaceuticals$5,500,000$2,750,000
EDGAR ↗Jul 8, 2013PLX PHARMA INC.DPharmaceuticals$9,000,000$9,000,000
EDGAR ↗Jun 17, 2013NANOSPECTRA BIOSCIENCES INCDOther Health Care$700,000$525,000
EDGAR ↗Jun 4, 2013NANOSPECTRA BIOSCIENCES INCDOther Health Care$849,999$849,999
EDGAR ↗Jun 4, 2013NANOSPECTRA BIOSCIENCES INCDOther Health Care$1,572,500$1,572,500
EDGAR ↗Mar 19, 2013PLX PHARMA INC.DPharmaceuticals$8,273,297$8,273,297
EDGAR ↗Feb 25, 2013PLx Pharma Inc.DPharmaceuticals$1,750,000$930,000
EDGAR ↗Apr 23, 2012PLx Pharma Inc.DPharmaceuticals$2,500,000$507,500
EDGAR ↗Feb 15, 2012Nuo Therapeutics, Inc.DBiotechnology$21,000,000$21,000,000
EDGAR ↗Nov 7, 2011PLx Pharma Inc.D/APharmaceuticals$3,000,000$2,740,000
EDGAR ↗Oct 5, 2011PLX PHARMA INC.DPharmaceuticals$7,000,000$2,893,965
EDGAR ↗Jul 26, 2011Nuo Therapeutics, Inc.DBiotechnology$1,300,000$1,300,000
EDGAR ↗Jul 26, 2011Nuo Therapeutics, Inc.DBiotechnology$600,000$600,000
EDGAR ↗May 4, 2011Nuo Therapeutics, Inc.DBiotechnology$325,000$325,000
EDGAR ↗Nov 16, 2010NANOSPECTRA BIOSCIENCES INCDOther Health Care$1,200,000$872,973
EDGAR ↗Oct 19, 2010Nuo Therapeutics, Inc.DBiotechnology$10,000,000$146,853
EDGAR ↗Aug 9, 2010PLX PHARMA INC.DPharmaceuticals$6,000,000$2,000,020
EDGAR ↗Jul 30, 2010PLx Pharma Inc.DPharmaceuticals$2,500,000$1,070,000
EDGAR ↗Apr 22, 2010Nuo Therapeutics, Inc.DBiotechnology$3,650,000$3,650,000
EDGAR ↗Jul 9, 2009PLX PHARMA INC.DPharmaceuticals$3,106,961$3,106,961

Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Aug 4, 2025. Industry history, as reported on each offering's latest filing: Previous offerings: Pharmaceuticals (2009), Biotechnology (2010), Pharmaceuticals (2010), Biotechnology (2010), Other Health Care (2010), Biotechnology (2011), Pharmaceuticals (2011), Biotechnology (2012), Pharmaceuticals (2012–2013), Other Health Care (2013), Pharmaceuticals (2013), Biotechnology (2013), Other Health Care (2014–2015), Pharmaceuticals (2016), Biotechnology (2016), Other Health Care (2017), Pharmaceuticals (2017), Biotechnology (2018), Pharmaceuticals (2019–2020), Other Health Care (2020), Pharmaceuticals (2020). Latest offering: Other Health Care (2022–2025; most recent Aug 4, 2025).

People across the group

NameRolesIssuers hereFirst → last listed
DJ David JordenExecutive Officer, Director4Jul 9, 2009 → Aug 4, 2025
MV Michael ValentinoDirector, Executive Officer2Mar 19, 2013 → Nov 30, 2020
NG Natasha GiordanoExecutive Officer, Director2Mar 11, 2016 → Nov 30, 2020
KC Kirk CalhounDirector2Mar 11, 2016 → Nov 30, 2020
GB Gary BalkemaDirector2Mar 11, 2016 → Nov 30, 2020
JH John W. Hadden IIDirector2Mar 11, 2016 → Nov 30, 2020
GM Gary MossmanExecutive Officer2Aug 9, 2010 → Jun 28, 2017
DA David AndersonDirector2Jul 9, 2009 → Jul 8, 2013
CW C. Eric WinzerDirector1Apr 22, 2010 → Aug 4, 2025
SP Scott PittmanDirector1May 20, 2016 → Aug 4, 2025
PM Paul MintzDirector1Jun 12, 2018 → Aug 4, 2025
PC Peter ClausenExecutive Officer1May 20, 2016 → Aug 4, 2025
PP Patrick PaceDirector1Nov 16, 2010 → Mar 15, 2023
GG Glenn GoodrichExecutive Officer1Jun 4, 2013 → Mar 15, 2023
BN Bradley NybergDirector1Aug 29, 2014 → Mar 15, 2023
BS Blair ShamelDirector1Dec 15, 2015 → Mar 15, 2023
KS Kevin P. SmithDirector1Sep 8, 2020 → Mar 15, 2023
RC Robert CasaleDirector1Jun 28, 2017 → Nov 30, 2020
AB Anthony BartshDirector1May 29, 2020 → Nov 30, 2020
RC Rita O'ConnorExecutive Officer1Mar 4, 2019 → Nov 30, 2020
ED Efthymios DeliargyrisExecutive Officer1Mar 4, 2019 → Mar 4, 2019
EW Eric C. WinzerDirector1Jul 26, 2011 → Jun 12, 2018
LA LAWRENCE S ATINSKYDirector1May 20, 2016 → Jun 12, 2018
DL David P. LuciExecutive Officer, Director, Promoter1Jul 30, 2010 → Jun 28, 2017
BP Brian PryorDirector1Feb 10, 2017 → Feb 10, 2017
JG Joseph Del GuercioDirector1Feb 15, 2012 → May 20, 2016
UM Upendra MarathiExecutive Officer1Mar 11, 2016 → Mar 11, 2016
BC Bob CasaleDirector1Mar 11, 2016 → Mar 11, 2016
RZ Ron ZimmermanExecutive Officer1Mar 11, 2016 → Mar 11, 2016
DB David BristolDirector1Jun 4, 2013 → Dec 15, 2015
JW Jennifer WestDirector1Nov 16, 2010 → Aug 29, 2014
SS Steven A. ShallcrossExecutive Officer1Dec 10, 2013 → Dec 10, 2013
SK Stephen KeithDirector1Apr 22, 2010 → Dec 10, 2013
MR Martin P. RosendaleDirector, Executive Officer1Apr 22, 2010 → Dec 10, 2013
MM MARK T. MCLOUGHLINDirector1Oct 19, 2010 → Dec 10, 2013
RK Richard KentDirector1Feb 15, 2012 → Dec 10, 2013
LH LYLE A. HOHNKEDirector1Feb 15, 2012 → Dec 10, 2013
RD Robert J. DeLucciaExecutive Officer, Director, Promoter1Jul 30, 2010 → Jul 22, 2013
SH Steven HurdDirector1Nov 7, 2011 → Jul 22, 2013
JT John TerranaDirector1Nov 7, 2011 → Jul 22, 2013
JD Jack H. DeanDirector1Nov 7, 2011 → Jul 22, 2013
WM William McSherry, Jr.Director1Nov 7, 2011 → Jul 22, 2013
CC Christopher CoughlinDirector1Feb 25, 2013 → Jul 22, 2013
JL John LeoneDirector1Feb 25, 2013 → Jul 22, 2013
EZ Ellen ZaroffDirector1Jul 22, 2013 → Jul 22, 2013
MD Michael DuffyDirector1Jul 22, 2013 → Jul 22, 2013
TB Tim BlackDirector1Jul 9, 2009 → Jul 8, 2013
LL Lenard M. LichtenbergerDirector1Jul 9, 2009 → Jul 8, 2013
RZ Ronald R. ZimmermanExecutive Officer, Director1Aug 9, 2010 → Jul 8, 2013
AS Alexander F. SeelenbergerDirector1Mar 19, 2013 → Jul 8, 2013
PM Peter MannDirector1Jul 8, 2013 → Jul 8, 2013
MK Milos KoterecDirector1Nov 7, 2011 → Apr 23, 2012
AM ANDREW S. MASLANExecutive Officer1Apr 22, 2010 → Feb 15, 2012
JB James S. BensonDirector1Apr 22, 2010 → Feb 15, 2012
CM CRAIG B. MENDELSOHNDirector1Oct 19, 2010 → Jul 26, 2011
KS KEITH N. STEPHENDirector1Oct 19, 2010 → Jul 26, 2011
PV Patrick P. VanekExecutive Officer1Jul 26, 2011 → Jul 26, 2011
BJ BENSON S. JAMESDirector1Oct 19, 2010 → May 4, 2011
JP J Donald PayneExecutive Officer, Director1Nov 16, 2010 → Nov 16, 2010
CM CRAIG B. MENDELSONDirector1Apr 22, 2010 → Apr 22, 2010

Business registration (state registry / Secretary of State)

1 of 4 issuers have a matched state registry record — records by status: active 1.

Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file). A registry listing is the state's own record of the entity; it says nothing about the offering itself.

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Plx Pharma.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Plx Pharma as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Public profiles and social

No website or social profile named in Plx Pharma's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #63,866 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Export this report as PDF · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Change history

No corrections have been requested for this page.

Request a correction

Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.

Sponsor response

Add a sourced explanation next to any fact. Reviewed before publishing.

Grouping is PartnerFacts' inference from public filings (shared related persons, management entities, business address). Everything else on this page is drawn from the filings themselves. Not the same sponsor? Request a correction.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: HOUSTON), TX). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Texas re:SearchTX court records ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Texas Secretary of State business search ↗New Jersey Secretary of State business search ↗OpenCorporates ↗